| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 DNAH7 SNRNP200 | 1.02e-05 | 441 | 223 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK38 SRMS ACVR2B ACVRL1 NEK9 AK7 MAP3K5 BLK AURKA TTBK1 PIP5K1B NME1 CLP1 WNK2 POLA1 SCYL3 TEP1 PIKFYVE MB21D2 RPAP1 GYS2 NT5C2 MAST1 PRKG2 EPHA10 | 5.22e-05 | 938 | 223 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 DNAH7 ARL4A RABL2A RERGL ENTPD3 SNRNP200 | 1.70e-04 | 775 | 223 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 NUDT13 DNAH7 ARL4A RABL2A RERGL ENTPD3 SNRNP200 | 1.89e-04 | 839 | 223 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 NUDT13 DNAH7 ARL4A RABL2A RERGL ENTPD3 SNRNP200 | 1.92e-04 | 840 | 223 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 NUDT13 DNAH7 ARL4A RABL2A RERGL ENTPD3 SNRNP200 | 1.92e-04 | 840 | 223 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A ABCC4 ABCA1 ABCA3 HSP90AB4P ERCC6L ATP8A2 ABCB4 KIF9 MDN1 DNAH9 KIF13B ATP13A4 INO80 DNAH7 DNAH1 SNRNP200 | 1.95e-04 | 614 | 223 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.51e-04 | 28 | 223 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 3.70e-04 | 3 | 223 | 2 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 3.70e-04 | 3 | 223 | 2 | GO:0052810 | |
| GeneOntologyMolecularFunction | kinase activity | STK38 SRMS ACVR2B ACVRL1 NEK9 AK7 MAP3K5 BLK AURKA TTBK1 PIP5K1B NME1 CLP1 WNK2 SCYL3 PIKFYVE NT5C2 MAST1 PRKG2 EPHA10 | 3.80e-04 | 764 | 223 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 6.91e-04 | 16 | 223 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | floppase activity | 6.91e-04 | 16 | 223 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 7.34e-04 | 4 | 223 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.91e-04 | 18 | 223 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK38 SRMS ACVR2B ACVRL1 NEK9 MAP3K5 BLK AURKA TTBK1 PIP5K1B CLP1 WNK2 SCYL3 PIKFYVE NT5C2 MAST1 PRKG2 EPHA10 | 1.06e-03 | 709 | 223 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.11e-03 | 70 | 223 | 5 | GO:0003777 | |
| GeneOntologyBiologicalProcess | cilium organization | ABCC4 USP9X DISC1 FNBP1L AK7 CEP350 AURKA TBC1D21 WDR44 SYNE1 PTPN23 ARMC9 DNAH7 DNAH1 TBC1D13 C2CD3 RABL2A AVIL TTC17 | 9.86e-07 | 476 | 221 | 19 | GO:0044782 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ABCC4 USP9X DISC1 FNBP1L TENM2 AK7 CEP350 TBC1D21 WDR44 STON1 P2RY12 SYNE1 PTPN23 ARMC9 CAV1 DNAH7 OPHN1 DNAH1 TBC1D13 C2CD3 RABL2A AVIL | 3.41e-06 | 670 | 221 | 22 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | ABCC4 USP9X DISC1 FNBP1L TENM2 AK7 CEP350 TBC1D21 WDR44 STON1 P2RY12 SYNE1 PTPN23 ARMC9 CAV1 DNAH7 OPHN1 DNAH1 TBC1D13 C2CD3 RABL2A AVIL | 4.86e-06 | 685 | 221 | 22 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | ABCC4 USP9X DISC1 FNBP1L AK7 CEP350 TBC1D21 WDR44 SYNE1 PTPN23 ARMC9 DNAH7 DNAH1 TBC1D13 C2CD3 RABL2A AVIL | 6.48e-06 | 444 | 221 | 17 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABCA1 ABCA3 USP9X SPTB SPTBN1 CLASP2 FNBP1L ACVRL1 TENM2 ANKRD53 KIF9 TTBK1 SACS IL1RAPL2 RAPGEF3 TBC1D21 WDR44 P2RY12 STXBP5 SYNE1 CAPN1 CAV1 EML3 PIKFYVE LEFTY2 TBC1D13 LEFTY1 AVIL | 7.64e-05 | 1189 | 221 | 28 | GO:0044087 |
| GeneOntologyBiologicalProcess | organelle assembly | RELN ABCC4 ABCA3 USP9X DISC1 CLASP2 FNBP1L AK7 CEP350 AURKA KIF9 MDN1 PISD TBC1D21 WDR44 SYNE1 PTPN23 ARMC9 INO80 DNAH7 EML3 DNAH1 PIKFYVE TBC1D13 C2CD3 RABL2A AVIL | 9.16e-05 | 1138 | 221 | 27 | GO:0070925 |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 9.72e-05 | 9 | 221 | 3 | GO:0006198 | |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 1.14e-04 | 2 | 221 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | reproductive senescence | 1.14e-04 | 2 | 221 | 2 | GO:1990636 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 1.14e-04 | 2 | 221 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 1.14e-04 | 2 | 221 | 2 | GO:1900123 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCC4 ABCA3 SGSM1 HLA-DPA1 ATP8A2 NEU3 ITGAV CLCN5 SORCS2 AP3M2 TMEM163 ARHGAP21 WDR44 ATP13A4 STON1 DSP WFS1 STXBP5 UBR4 HGSNAT CAV1 CEMIP MMP25 PIKFYVE MTMR4 MALRD1 TLR3 PAM SMO | 1.48e-04 | 1307 | 223 | 29 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ABCC4 ABCA3 SGSM1 HLA-DPA1 ATP8A2 NEU3 ITGAV CLCN5 SORCS2 AP3M2 TMEM163 ARHGAP21 WDR44 ATP13A4 STON1 DSP WFS1 STXBP5 UBR4 HGSNAT CAV1 CEMIP MMP25 PIKFYVE MTMR4 MALRD1 TLR3 PAM SMO | 1.87e-04 | 1325 | 223 | 29 | GO:0012506 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.43e-04 | 161 | 223 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | cell surface | ABCC4 ABCA1 HLA-DPA1 SPTB NEU3 ACVRL1 ITGAV MAP3K5 LILRB5 IL31RA P2RY12 CAPN2 MUC16 DUOX2 CASR CAV1 APOH ADGRG6 MMP25 CD22 IGHD TLR3 PAM IL6ST KCNH5 | 3.54e-04 | 1111 | 223 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.76e-04 | 129 | 223 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 4.85e-04 | 93 | 223 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | cilium | CEP104 CFAP95 ABCC4 USP9X DISC1 IRS1 AK7 AURKA KIF9 TBC1D21 DNAH9 BRWD1 PTPN23 ARMC9 CAV1 DNAH7 CRB1 DNAH1 C2CD3 RABL2A SMO | 6.54e-04 | 898 | 223 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | calpain complex | 6.70e-04 | 4 | 223 | 2 | GO:0110158 | |
| Domain | SPEC | 3.75e-05 | 32 | 225 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.75e-05 | 32 | 225 | 5 | IPR018159 | |
| Pubmed | USP9X ATP8A2 STK38 SRMS IRS1 BLK AURKA TTBK1 LIPM HCFC2 WNK2 RBBP7 CAPN1 CAPN2 USP46 SACM1L MMP25 MTMR4 KCNH5 | 4.49e-07 | 730 | 229 | 19 | 34857952 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 ABCC4 SGSM1 SPTB RTN3 CLASP2 FNBP1L ACVR2B NEK9 AFMID OS9 PISD WNK2 RASA2 CAPN1 FRMPD1 HNRNPA3 PORCN TEP1 JMJD1C ADGRG6 DNAH1 AOPEP NT5C2 MAST1 TTC17 VGLL4 PRORP | 6.56e-07 | 1489 | 229 | 28 | 28611215 |
| Pubmed | 3.13e-06 | 61 | 229 | 6 | 20548051 | ||
| Pubmed | CSMD3 TENM2 GANAB RRP12 ARHGAP21 STXBP5 SYNE1 FRMPD1 FHIP2A SACM1L RPAP1 MAST1 LARGE1 | 3.54e-06 | 407 | 229 | 13 | 12693553 | |
| Pubmed | NEK9 SPATA31D4 SPATA31D3 WNK2 SYNE1 UBR4 ACOT1 DNAH7 PIKFYVE MAST1 | 3.74e-06 | 233 | 229 | 10 | 37704626 | |
| Pubmed | RELN PDE7A AKAP17A USP9X SPTB SPTBN1 MCF2L2 NCKAP5 RYR3 CEP350 FBN1 SACS ARHGAP21 RASAL2 BRWD1 SUPT20H DSP SYNE1 UBR4 ACOT1 ZFC3H1 MAST1 TTC17 SNRNP200 | 4.90e-06 | 1285 | 229 | 24 | 35914814 | |
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 21364967 | ||
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 37831760 | ||
| Pubmed | Association of the calpain/calpastatin network with subcellular organelles. | 5.55e-06 | 6 | 229 | 3 | 14559243 | |
| Pubmed | NEK9 CEP350 TTBK1 SACS PLEKHH2 KIF13B PTPN23 ZFC3H1 JMJD1C PIKFYVE TSPYL5 ZNF518B PRORP SNRNP200 | 5.75e-06 | 493 | 229 | 14 | 15368895 | |
| Pubmed | 8.87e-06 | 257 | 229 | 10 | 16335952 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX19A HSP90AB4P USP9X SPTBN1 RTN3 CLASP2 NEK9 GANAB MDN1 UTP15 GLO1 RRP12 RASAL2 DSP POLA1 SYNE1 UBR4 NIPSNAP1 HNRNPA3 DUOX2 SACM1L LIG3 NUP155 LTV1 SNRNP200 | 9.04e-06 | 1425 | 229 | 25 | 30948266 |
| Pubmed | 9.67e-06 | 7 | 229 | 3 | 20962236 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX19B AKAP17A ERCC6L USP9X CLASP2 NEK9 AURKA TTBK1 GANAB RRP12 SERINC3 PIP5K1B SPOP RASAL2 DSP UBR4 NIPSNAP1 HNRNPA3 JMJD1C EML3 CRB1 LIG3 SNRNP200 | 1.52e-05 | 1284 | 229 | 23 | 17353931 |
| Pubmed | 1.54e-05 | 8 | 229 | 3 | 21802298 | ||
| Pubmed | 2.81e-05 | 89 | 229 | 6 | 36861887 | ||
| Pubmed | SPTB SPTBN1 CLASP2 LRRC2 NEK9 MAP3K5 OS9 ARHGAP21 COL6A3 DSP SYNE1 JMJD1C IL6ST | 2.93e-05 | 497 | 229 | 13 | 23414517 | |
| Pubmed | Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. | 3.27e-05 | 10 | 229 | 3 | 19124510 | |
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 17913787 | ||
| Pubmed | 3.39e-05 | 92 | 229 | 6 | 20301317 | ||
| Pubmed | Calpain-2 participates in the process of calpain-1 inactivation. | 4.32e-05 | 2 | 229 | 2 | 33078830 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 27579791 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22187946 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15471877 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 38019257 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20056823 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 10053005 | ||
| Pubmed | Mutation analysis of human LEFTY A and LEFTY B genes in children with Ivemark syndrome. | 4.32e-05 | 2 | 229 | 2 | 11100524 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 23680464 | ||
| Pubmed | Involvement of calpains in growth factor-mediated migration. | 4.32e-05 | 2 | 229 | 2 | 16971167 | |
| Pubmed | Membrane domain organization of myelinated axons requires βII spectrin. | 4.32e-05 | 2 | 229 | 2 | 24217619 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 29258546 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28594313 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22335024 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 27185592 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 32333821 | ||
| Pubmed | Epistasis between polymorphisms in ACVR2B and ADAMTS19 is associated with premature ovarian failure. | 4.32e-05 | 2 | 229 | 2 | 25051287 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20193680 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28193222 | ||
| Pubmed | Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. | 4.32e-05 | 2 | 229 | 2 | 16510495 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 1761551 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 9989581 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21340433 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 1939075 | ||
| Pubmed | Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. | 4.32e-05 | 2 | 229 | 2 | 23722906 | |
| Pubmed | Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways. | 4.32e-05 | 2 | 229 | 2 | 33409963 | |
| Pubmed | Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells. | 4.32e-05 | 2 | 229 | 2 | 24297165 | |
| Pubmed | Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. | 4.32e-05 | 2 | 229 | 2 | 17038673 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 23480827 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 29890521 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 12783889 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 27622212 | ||
| Pubmed | Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. | 4.32e-05 | 2 | 229 | 2 | 23850619 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 14699500 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 11877449 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20005844 | ||
| Pubmed | Isolation, characterization, and function of EBAF/LEFTY B: role in infertility. | 4.32e-05 | 2 | 229 | 2 | 21401636 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 30699353 | ||
| Pubmed | Inhibition of calpain stabilises podosomes and impairs dendritic cell motility. | 4.32e-05 | 2 | 229 | 2 | 16723743 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 24285894 | ||
| Pubmed | [Expression of calpain 1 and calpain 2 during the skin incised wound healing in mice]. | 4.32e-05 | 2 | 229 | 2 | 17619446 | |
| Pubmed | Calpain 1 and 2 are required for RNA replication of echovirus 1. | 4.32e-05 | 2 | 229 | 2 | 18032503 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 32745796 | ||
| Pubmed | Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer. | 4.32e-05 | 2 | 229 | 2 | 27152521 | |
| Pubmed | Cloning of m-calpain 80 kD subunit from the axonal degeneration-resistant WLD(S) mouse mutant. | 4.32e-05 | 2 | 229 | 2 | 9669314 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21586796 | ||
| Pubmed | Vitamin D₃ regulation of body fat, cytokines, and calpain gene expression. | 4.32e-05 | 2 | 229 | 2 | 25520983 | |
| Pubmed | m-Calpain is required for preimplantation embryonic development in mice. | 4.32e-05 | 2 | 229 | 2 | 16433929 | |
| Pubmed | Calpains are required for invasive and metastatic potentials of human HCC cells. | 4.32e-05 | 2 | 229 | 2 | 23733271 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 24147624 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 19781581 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22432027 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 17359359 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21951852 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21478209 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 30177812 | ||
| Pubmed | The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. | 4.32e-05 | 2 | 229 | 2 | 12490715 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 14980313 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 30098223 | ||
| Pubmed | Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. | 4.32e-05 | 2 | 229 | 2 | 20171171 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 9496783 | ||
| Pubmed | A functional role of LEFTY during progesterone therapy for endometrial carcinoma. | 4.32e-05 | 2 | 229 | 2 | 29268772 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22140070 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 34757783 | ||
| Pubmed | Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. | 4.32e-05 | 2 | 229 | 2 | 19902402 | |
| Pubmed | Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. | 4.32e-05 | 2 | 229 | 2 | 19505932 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 29230527 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 23224054 | ||
| Pubmed | IGF-I regulates caveolin 1 and IRS1 interaction in caveolae. | 4.32e-05 | 2 | 229 | 2 | 15003536 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 12011038 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 29286065 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28419469 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15277237 | ||
| Pubmed | Lefty is expressed in mouse endometrium in estrous cycle and peri-implantation period. | 4.32e-05 | 2 | 229 | 2 | 15640253 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15302874 | ||
| Pubmed | 4.47e-05 | 11 | 229 | 3 | 12832401 | ||
| Pubmed | The SIL gene is required for mouse embryonic axial development and left-right specification. | 4.47e-05 | 11 | 229 | 3 | 10385121 | |
| Pubmed | 5.13e-05 | 99 | 229 | 6 | 19730683 | ||
| Pubmed | PDE7A SPTBN1 RTN3 CLASP2 GANAB MDN1 UTP15 SACS RRP12 OS9 RASAL2 WFS1 SYNE1 UBR4 NIPSNAP1 ACOT1 CAV1 ZFC3H1 NUP155 RPAP1 TTC17 LTV1 SNRNP200 QRSL1 | 5.21e-05 | 1487 | 229 | 24 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX19B DDX19A RTN3 GANAB MDN1 UTP15 GLO1 RRP12 NME1 WDR44 PDSS2 SYNE1 UBR4 NIPSNAP1 HNRNPA3 ACOT1 CAV1 PIKFYVE NUP155 RPAP1 OGDHL TTC17 PRORP QRSL1 | 5.72e-05 | 1496 | 229 | 24 | 32877691 |
| Cytoband | 1q42.1 | 2.61e-05 | 12 | 229 | 3 | 1q42.1 | |
| GeneFamily | Dyneins, axonemal | 3.63e-04 | 17 | 152 | 3 | 536 | |
| GeneFamily | WD repeat domain containing | 3.80e-04 | 262 | 152 | 9 | 362 | |
| GeneFamily | Phosphodiesterases | 1.04e-03 | 24 | 152 | 3 | 681 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.43e-03 | 7 | 152 | 2 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.81e-03 | 206 | 152 | 7 | 682 | |
| GeneFamily | Nucleoporins | 2.42e-03 | 32 | 152 | 3 | 1051 | |
| GeneFamily | EF-hand domain containing | 2.55e-03 | 219 | 152 | 7 | 863 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP | TRAF5 FNBP1L ABCB4 AP3M2 DSP C2CD3 CD22 IGHD TSPYL5 SP140 LARGE1 | 1.18e-06 | 197 | 225 | 11 | M4485 |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | SPTBN1 STK38 RTN3 CLASP2 AURKA KIF13B AMDHD2 PHOSPHO2 OPHN1 TLR3 | 9.24e-06 | 199 | 225 | 10 | M8639 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | DDX19A SRRD CLCN5 QDPR NIPSNAP1 ARMC9 MTMR4 CD22 PCIF1 MASP2 SP140 | 2.14e-05 | 267 | 225 | 11 | M41130 |
| Coexpression | HALLMARK_COAGULATION | 2.65e-05 | 138 | 225 | 8 | M5946 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 5.47e-05 | 197 | 225 | 9 | M3136 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 5.47e-05 | 197 | 225 | 9 | M3081 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 5.69e-05 | 198 | 225 | 9 | M7610 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 5.92e-05 | 199 | 225 | 9 | M6412 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 5.92e-05 | 199 | 225 | 9 | M4444 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 6.15e-05 | 200 | 225 | 9 | M5995 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 6.15e-05 | 200 | 225 | 9 | M8541 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP | 6.15e-05 | 200 | 225 | 9 | M8605 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN | 6.15e-05 | 200 | 225 | 9 | M9784 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN | 6.15e-05 | 200 | 225 | 9 | M7492 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | 6.15e-05 | 200 | 225 | 9 | M6185 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP | 6.15e-05 | 200 | 225 | 9 | M4440 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 6.95e-05 | 158 | 225 | 8 | M372 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 9.61e-05 | 212 | 225 | 9 | M39221 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.02e-08 | 183 | 229 | 10 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | Control-Lymphoid_B|Control / Disease group, lineage and cell class | 6.02e-08 | 191 | 229 | 10 | 0a760cd3a48c487ec899adb882fddea8914cfe0c | |
| ToppCell | PBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.97e-08 | 194 | 229 | 10 | a8daf73c186a15adb9ea02793d4bd9cb35c66290 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CPAMD8 ABCC4 DCDC1 PLEKHH2 ATP13A4 SYNE1 CASR DNAH7 NTN4 AOPEP | 6.97e-08 | 194 | 229 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | PBMC-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.97e-08 | 194 | 229 | 10 | 39121c7d537ac103f6959271d814fd327be7114f | |
| ToppCell | COVID-19_Moderate-B_naive|World / disease group, cell group and cell class | 6.97e-08 | 194 | 229 | 10 | 1f81d618799e482a36dce528bba70f52cc69a901 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.97e-08 | 194 | 229 | 10 | 60542304899b99caa38e4abf6b71ba986fa6c399 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.97e-08 | 194 | 229 | 10 | ad9a8cc57f54bdec4cd6990b2cace947b7a163c9 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.07e-07 | 135 | 229 | 8 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Control-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type | 5.67e-07 | 187 | 229 | 9 | 90c9b1a51539838323325f563be4adf5fdf1b38f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.47e-07 | 190 | 229 | 9 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.47e-07 | 190 | 229 | 9 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 6.47e-07 | 190 | 229 | 9 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.76e-07 | 191 | 229 | 9 | a831e30f37aff329d83fac9bdb84f783075d5df6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.76e-07 | 191 | 229 | 9 | 2453064c39b359088d43d52792bf829f83442c82 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 7.07e-07 | 192 | 229 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.07e-07 | 192 | 229 | 9 | 800edadd1d1ba6b7e0a0398030dd4b61c9c480c7 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.38e-07 | 193 | 229 | 9 | 94b5a4a4e9faaa95cb72907a2f0497429c72e516 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.38e-07 | 193 | 229 | 9 | cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.38e-07 | 193 | 229 | 9 | ddc06227f2580774d9f34729dff912d6a9155f9c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-07 | 193 | 229 | 9 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.38e-07 | 193 | 229 | 9 | 437ae3b10d169bb371f7b92d57a77f43e3f8d64d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.38e-07 | 193 | 229 | 9 | 2416b39e18ce0c7016c2351f79bf1b2ecc183a98 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 7.44e-07 | 142 | 229 | 8 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.70e-07 | 194 | 229 | 9 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | Control-Lymphoid_B-B_naive|Control / Disease group, lineage and cell class | 7.70e-07 | 194 | 229 | 9 | 4f9600960a287cfc020c06b4af3528d4e5797916 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.70e-07 | 194 | 229 | 9 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.70e-07 | 194 | 229 | 9 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.04e-07 | 195 | 229 | 9 | 8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_intermediate|COVID-19_Convalescent / Disease group, lineage and cell class | 8.04e-07 | 195 | 229 | 9 | b213f19dad4c8d5a6bf20cadb1135fb2bb0b40ee | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_naive|COVID-19_Severe / Disease group, lineage and cell class | 8.04e-07 | 195 | 229 | 9 | 71563e838fcda34a9a209c5433e0d84420373402 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.04e-07 | 195 | 229 | 9 | e830f0c545be87a1056a4505bdf6845e5ac7750d | |
| ToppCell | remission-B_intermediate|remission / disease stage, cell group and cell class | 8.04e-07 | 195 | 229 | 9 | ee14d00eb5800fadd57c2304e9461534d8668674 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.39e-07 | 196 | 229 | 9 | d7e6c89cb49933b4a86d26d15f6772f2481d37ef | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_naive|COVID-19_Mild / Disease group, lineage and cell class | 8.39e-07 | 196 | 229 | 9 | 4b3ceb1f85be0fa8d53dc5548326ab0a5239a8b9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.39e-07 | 196 | 229 | 9 | fcbfd8c4771d99a45fc53e482ef98edabe8ef591 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.39e-07 | 196 | 229 | 9 | f45cb8f714ae7ac800768df65f299b98a2d42962 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.75e-07 | 197 | 229 | 9 | f7a8440d2b8b17d9726c6fe3dd383effbfebab13 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.75e-07 | 197 | 229 | 9 | 7cae4f3eabfebce101de7bb7defb17d6c5360b58 | |
| ToppCell | COVID-19_Mild-Lymphoid_B|COVID-19_Mild / Disease group, lineage and cell class | 8.75e-07 | 197 | 229 | 9 | ff25c0e184bd0f068014bc3f5eba3aee17511b87 | |
| ToppCell | Control-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class | 9.52e-07 | 199 | 229 | 9 | ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate|COVID-19_Convalescent / Disease, condition lineage and cell class | 9.93e-07 | 200 | 229 | 9 | fdc0df661a34e0db3279334bdeebfdf60c85ef41 | |
| ToppCell | MS-IIF-Lymphocyte-B|IIF / Disease, condition lineage and cell class | 9.93e-07 | 200 | 229 | 9 | a0f3362b7ddfc122e30e75fb541bb0b7d0321c72 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 149 | 229 | 8 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 158 | 229 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 158 | 229 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-06 | 160 | 229 | 8 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-06 | 165 | 229 | 8 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 165 | 229 | 8 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-06 | 173 | 229 | 8 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.57e-06 | 175 | 229 | 8 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.57e-06 | 175 | 229 | 8 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.72e-06 | 176 | 229 | 8 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.04e-06 | 178 | 229 | 8 | b132605f237e766a21042b9a65a564d64c4fec10 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-06 | 178 | 229 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.04e-06 | 178 | 229 | 8 | 99cd5e517855f1a2d6d75fb2d439751f884862c1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 178 | 229 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.21e-06 | 179 | 229 | 8 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-06 | 180 | 229 | 8 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.57e-06 | 181 | 229 | 8 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-06 | 184 | 229 | 8 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | Control-Lymphocyte-B|Control / Disease, Lineage and Cell Type | 5.37e-06 | 185 | 229 | 8 | cb61b5ff6a2ef71c94469c35cafc21df5bcf61b1 | |
| ToppCell | IIF-Lymphocyte-B-B_naive|IIF / Disease, Lineage and Cell Type | 5.37e-06 | 185 | 229 | 8 | dec48908addfc71f32f5ce0ce73f2926e476f60b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.55e-06 | 132 | 229 | 7 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-06 | 186 | 229 | 8 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-06 | 186 | 229 | 8 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-06 | 187 | 229 | 8 | d01926be1c8846a25fb6706e26b56b808b69f8f0 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass | 5.81e-06 | 187 | 229 | 8 | 904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3 | |
| ToppCell | IIF-Lymphocyte-B|IIF / Disease, Lineage and Cell Type | 5.81e-06 | 187 | 229 | 8 | bba950ad8f4cd9be416516043724fc22786d879e | |
| ToppCell | Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, Lineage and Cell Type | 5.81e-06 | 187 | 229 | 8 | 027aa7b5be402fc82ae13c346dfb4c0c751a07e9 | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 5.81e-06 | 187 | 229 | 8 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-06 | 187 | 229 | 8 | 83582c499cda6306fe5f66f2ac97e27ff420e228 | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 5.81e-06 | 187 | 229 | 8 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.05e-06 | 188 | 229 | 8 | fa1346902021c3a6557555ada0fd37b29cf9d5ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-06 | 188 | 229 | 8 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.05e-06 | 188 | 229 | 8 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 6.29e-06 | 189 | 229 | 8 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 189 | 229 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 189 | 229 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.29e-06 | 189 | 229 | 8 | b4237437452f86e745b91285980c48a02a95f4c6 | |
| ToppCell | 10x5'-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 6.29e-06 | 189 | 229 | 8 | 9837dca502c9a7f42efb0bc74f3e88e7461e7dc8 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 189 | 229 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Immature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.29e-06 | 189 | 229 | 8 | 5776f842b3047d21ccdc44db884bfd210823c7da | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 189 | 229 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.53e-06 | 190 | 229 | 8 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 6.53e-06 | 190 | 229 | 8 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.53e-06 | 190 | 229 | 8 | e63945fa1dcd58bee129f1dd0c23b64a76241554 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.53e-06 | 190 | 229 | 8 | fa65bc5a178ae0c80a9bd4b282e4539493128a64 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-06 | 190 | 229 | 8 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|lymphoid / Lineage, cell class and subclass | 6.53e-06 | 190 | 229 | 8 | b8b05894e811e431d797ac4fa3ccff4963a154e7 | |
| ToppCell | lymphoid-B_cell|lymphoid / Lineage, cell class and subclass | 6.53e-06 | 190 | 229 | 8 | c451de643ee08c2ff1093e807c65d724237473c5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.53e-06 | 190 | 229 | 8 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-06 | 190 | 229 | 8 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.53e-06 | 190 | 229 | 8 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-06 | 190 | 229 | 8 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.53e-06 | 190 | 229 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.79e-06 | 191 | 229 | 8 | 3fc16e986aff5e0cd4f831e25e78a5b30beba7a8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.79e-06 | 191 | 229 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| Disease | Colorectal Carcinoma | CPAMD8 ABCC4 ABCA1 ABCA3 MCF2L2 CSMD3 ABCB4 AURKA SACS NME1 RASAL2 SYNE1 AMDHD2 LIG3 RPAP1 SNRNP200 IL6ST | 2.19e-05 | 702 | 219 | 17 | C0009402 |
| Disease | Situs ambiguous | 3.28e-05 | 9 | 219 | 3 | C1167664 | |
| Disease | cortical surface area measurement | EFCAB5 ADAMTS19 CPAMD8 RELN DCDC1 NBEAL1 ATP8A2 SPTBN1 NCKAP5 FNBP1L TENM2 FBN1 ARHGAP21 WNK2 STON1 CAPN2 DNAH7 SACM1L NTN4 AOPEP NT5C2 PAM AKAP10 PROC | 6.82e-05 | 1345 | 219 | 24 | EFO_0010736 |
| Disease | melanoma | 1.06e-04 | 248 | 219 | 9 | C0025202 | |
| Disease | urate measurement | DDX19B SYCP2L ABCA1 DCDC1 FNBP1L PIP5K1B CMAHP FBXO34 CAPN1 JMJD1C DNAH1 CEMIP NTN4 MALRD1 NT5C2 ZNF518B PROC LARGE1 | 1.36e-04 | 895 | 219 | 18 | EFO_0004531 |
| Disease | kit ligand measurement | 1.64e-04 | 3 | 219 | 2 | EFO_0010612 | |
| Disease | Situs ambiguus | 1.72e-04 | 15 | 219 | 3 | C0266642 | |
| Disease | white matter microstructure measurement | DCDC1 NBEAL1 DISC1 NCKAP5 TENM2 ARHGAP21 STON1 ARMC9 CRB1 ADGRG6 RERGL | 1.74e-04 | 390 | 219 | 11 | EFO_0005674 |
| Disease | Colorectal Neoplasms | 2.42e-04 | 277 | 219 | 9 | C0009404 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.90e-04 | 43 | 219 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.26e-04 | 4 | 219 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.77e-04 | 46 | 219 | 4 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.86e-04 | 21 | 219 | 3 | EFO_0000180, Orphanet_391311 | |
| Disease | Tourette syndrome | 5.20e-04 | 50 | 219 | 4 | EFO_0004895 | |
| Disease | diastolic blood pressure, systolic blood pressure | DCDC1 HLA-DPA1 CEP350 FBN1 CMAHP ARMC9 APOH DNAH7 CRB1 CEMIP LIG3 C2CD3 MALRD1 IGFBP1 | 5.22e-04 | 670 | 219 | 14 | EFO_0006335, EFO_0006336 |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 5.40e-04 | 5 | 219 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | Asplenia Syndrome | 5.40e-04 | 5 | 219 | 2 | C0175707 | |
| Disease | Polysplenia Syndrome | 5.40e-04 | 5 | 219 | 2 | C0265357 | |
| Disease | Right Atrial Isomerism | 5.40e-04 | 5 | 219 | 2 | C3178806 | |
| Disease | Left Atrial Isomerism | 5.40e-04 | 5 | 219 | 2 | C3178807 | |
| Disease | Metastatic melanoma | 6.98e-04 | 54 | 219 | 4 | C0278883 | |
| Disease | cytokine measurement | PADI4 DCDC1 ATP8A2 MROH5 OS9 CMAHP ARHGAP21 ATP13A4 PDSS2 PAM KCNH5 | 7.11e-04 | 461 | 219 | 11 | EFO_0004873 |
| Disease | triglycerides in large VLDL measurement | 8.02e-04 | 56 | 219 | 4 | EFO_0022178 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 8.07e-04 | 6 | 219 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Sjogren syndrome | 1.04e-03 | 60 | 219 | 4 | EFO_0000699 | |
| Disease | coiled-coil domain-containing protein 126 measurement | 1.12e-03 | 7 | 219 | 2 | EFO_0801482 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 1.12e-03 | 7 | 219 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | Goiter | 1.12e-03 | 7 | 219 | 2 | C0018021 | |
| Disease | proactivator polypeptide-like 1 measurement | 1.12e-03 | 7 | 219 | 2 | EFO_0801912 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 1.12e-03 | 7 | 219 | 2 | EFO_0008018 | |
| Disease | cortex volume change measurement, age at assessment | 1.15e-03 | 28 | 219 | 3 | EFO_0008007, EFO_0021500 | |
| Disease | Familial pulmonary arterial hypertension | 1.49e-03 | 8 | 219 | 2 | C1701939 | |
| Disease | matrix metalloproteinase 7 measurement | 1.49e-03 | 8 | 219 | 2 | EFO_0010591 | |
| Disease | Dickkopf-related protein 4 measurement | 1.49e-03 | 8 | 219 | 2 | EFO_0008110 | |
| Disease | Heterotaxy Syndrome | 1.49e-03 | 8 | 219 | 2 | C3178805 | |
| Disease | pantothenate measurement | 1.49e-03 | 8 | 219 | 2 | EFO_0021034 | |
| Disease | antiphospholipid syndrome (is_implicated_in) | 1.49e-03 | 8 | 219 | 2 | DOID:2988 (is_implicated_in) | |
| Disease | total lipids in large VLDL | 1.57e-03 | 67 | 219 | 4 | EFO_0022175 | |
| Disease | cortical thickness | CPAMD8 RELN DCDC1 NBEAL1 SPTBN1 NCKAP5 FNBP1L TENM2 FBN1 ARHGAP21 WNK2 STON1 JMJD1C SACM1L ARL4A MALRD1 PAM AKAP10 | 1.72e-03 | 1113 | 219 | 18 | EFO_0004840 |
| Disease | Polydactyly | 1.84e-03 | 117 | 219 | 5 | C0152427 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.91e-03 | 9 | 219 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.91e-03 | 9 | 219 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Intellectual Disability | ATP8A2 DISC1 SACS PISD SYNE1 PTPN23 ARMC9 FHIP2A NT5C2 LARGE1 | 1.98e-03 | 447 | 219 | 10 | C3714756 |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN USP9X ATP8A2 TENM2 CLCN5 SORCS2 COL6A3 NTN4 MALRD1 RERGL | 1.98e-03 | 447 | 219 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.04e-03 | 34 | 219 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.04e-03 | 34 | 219 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | serum alanine aminotransferase measurement | HLA-DPA1 DISC1 SRMS FNBP1L ABCB4 BLK FBN1 PISD WNK2 BRWD1 PDSS2 STON1 CASP10 APOH MMP25 | 2.24e-03 | 869 | 219 | 15 | EFO_0004735 |
| Disease | coffee consumption measurement, insomnia | 2.37e-03 | 10 | 219 | 2 | EFO_0004698, EFO_0006781 | |
| Disease | thrombosis (implicated_via_orthology) | 2.37e-03 | 10 | 219 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | age at onset, multiple sclerosis | 2.37e-03 | 10 | 219 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | Pulmonary arterial hypertension | 2.37e-03 | 10 | 219 | 2 | C2973725 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 2.37e-03 | 10 | 219 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.38e-03 | 75 | 219 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.40e-03 | 36 | 219 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | interleukin-6 measurement, response to stimulus | 2.89e-03 | 11 | 219 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Retinal Detachment | 2.89e-03 | 11 | 219 | 2 | C0035305 | |
| Disease | Situs Inversus | 2.89e-03 | 11 | 219 | 2 | C0037221 | |
| Disease | lip morphology measurement | 2.96e-03 | 189 | 219 | 6 | EFO_0007845 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.01e-03 | 80 | 219 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | pancreatitis (biomarker_via_orthology) | 3.03e-03 | 39 | 219 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 3.07e-03 | 255 | 219 | 7 | EFO_0009924 | |
| Disease | very low density lipoprotein particle size measurement | 3.21e-03 | 133 | 219 | 5 | EFO_0008594 | |
| Disease | cystatin C measurement | 3.27e-03 | 402 | 219 | 9 | EFO_0004617 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.41e-03 | 260 | 219 | 7 | EFO_0008317 | |
| Disease | Depression, Neurotic | 3.49e-03 | 41 | 219 | 3 | C0282126 | |
| Disease | Melancholia | 3.49e-03 | 41 | 219 | 3 | C0025193 | |
| Disease | Depressive Syndrome | 3.74e-03 | 42 | 219 | 3 | C0086133 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.74e-03 | 42 | 219 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | autistic disorder (is_implicated_in) | 3.74e-03 | 42 | 219 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | liver cirrhosis (is_implicated_in) | 4.00e-03 | 43 | 219 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | DDX19B AGPAT4 ABCB4 SORCS2 PISD PLEKHH2 CMAHP BRWD1 KIF13B APOH ZNF19 PCIF1 | 4.18e-03 | 663 | 219 | 12 | EFO_0004615 |
| Disease | Anxiety Disorders | 4.27e-03 | 44 | 219 | 3 | C0003469 | |
| Disease | Anxiety States, Neurotic | 4.27e-03 | 44 | 219 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 4.27e-03 | 44 | 219 | 3 | C1279420 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 4.59e-03 | 90 | 219 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.71e-03 | 14 | 219 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Hamman-Rich syndrome | 4.71e-03 | 14 | 219 | 2 | C0085786 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 4.71e-03 | 14 | 219 | 2 | C1150929 | |
| Disease | triglyceride measurement, phospholipid measurement | 4.77e-03 | 146 | 219 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | Endogenous depression | 4.84e-03 | 46 | 219 | 3 | C0011573 | |
| Disease | hepatoblastoma (is_marker_for) | 5.40e-03 | 15 | 219 | 2 | DOID:687 (is_marker_for) | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 5.40e-03 | 15 | 219 | 2 | EFO_0022328 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 5.76e-03 | 96 | 219 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.80e-03 | 153 | 219 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | glaucoma | 5.96e-03 | 154 | 219 | 5 | MONDO_0005041 | |
| Disease | coffee consumption, cups of coffee per day measurement | 6.14e-03 | 16 | 219 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | Idiopathic pulmonary arterial hypertension | 6.14e-03 | 16 | 219 | 2 | C3203102 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 6.42e-03 | 99 | 219 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | electrocardiography | HLA-DPA1 SPTBN1 STON1 ARMC9 CAV1 ZFC3H1 JMJD1C CEMIP LIG3 PAM | 6.53e-03 | 530 | 219 | 10 | EFO_0004327 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 6.72e-03 | 224 | 219 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.93e-03 | 17 | 219 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Familial primary pulmonary hypertension | 6.93e-03 | 17 | 219 | 2 | C0340543 | |
| Disease | cyclic adenosine monophosphate measurement | 6.93e-03 | 17 | 219 | 2 | EFO_0010473 | |
| Disease | protein C measurement | 6.93e-03 | 17 | 219 | 2 | EFO_0004633 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 6.93e-03 | 17 | 219 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 6.93e-03 | 17 | 219 | 2 | EFO_0022232 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 7.19e-03 | 53 | 219 | 3 | EFO_0022340 | |
| Disease | Liver Cirrhosis | 7.36e-03 | 103 | 219 | 4 | C0023890 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STFLFLVGQDDHNWK | 316 | Q86TX2 | |
| GWKATRLFHDSAVTS | 361 | Q8WV16 | |
| IDAWGSEHTVDSKCF | 136 | Q9Y2D0 | |
| SQDIHFWIGKDSSQD | 56 | O75366 | |
| RSWDGLFKFSQIHVD | 291 | Q4G0S4 | |
| FKEHSSLAFWKTDAS | 326 | P02749 | |
| SAGELKIADFGWSVH | 266 | O14965 | |
| VVSFATEHNWDSLDF | 1981 | Q7Z407 | |
| VFHLEVSEKDFESAW | 476 | Q9BXY5 | |
| AQELHVWTDKSSLFE | 376 | P49902 | |
| LVKFWLEAESFHSTT | 151 | O43572 | |
| TTWEMAFSGDDFHIK | 556 | Q4VNC1 | |
| CFEATKVGHEDSDWT | 186 | Q86SQ4 | |
| KSVHNGFAKEFWEET | 341 | P41180 | |
| GSLTAWFLKEVTDHA | 156 | P54840 | |
| EASSWKKQVSHDFLE | 546 | Q9NWN3 | |
| TKSYWFGEESDEKSH | 861 | O95477 | |
| SKTVTFHFWDVGGQE | 66 | P40617 | |
| ETVWHLEEFGQAFSF | 71 | P20036 | |
| TQTGSFFLKETEGWH | 166 | Q99758 | |
| FFLKETEGWHTTSLF | 171 | Q99758 | |
| WHGESVAVKIFSSRD | 221 | P37023 | |
| GDAHTNTVWKFTLTE | 796 | P19021 | |
| TKIFINNEWHDSVSG | 21 | P00352 | |
| SEGFATHLEDVFWAT | 501 | Q8N6M6 | |
| KWYLLSEHSGSVEDD | 406 | Q9NWX5 | |
| VFVHSAEGNEFWSAL | 176 | P07384 | |
| EFLVETFHDWITGKN | 206 | P09417 | |
| DIGISTWKEQTFLSH | 241 | Q86YH6 | |
| EGTHSFDGIWKASFT | 76 | Q03135 | |
| TEWFDHDKVSQTKGG | 326 | Q8WUJ3 | |
| ISGNHFWTAKDLTEE | 596 | Q9NRI5 | |
| AGLETTAWTKFSHLA | 1016 | Q9NTI2 | |
| FKHGEWTTTDDDITT | 126 | P54107 | |
| IHFEKEVGNSSIAWS | 446 | O75355 | |
| GELSFKSENQEEFWH | 1351 | Q6ZS30 | |
| GVADKVSWHSEYKDS | 21 | Q9Y388 | |
| EDLCNHSGKETWFSL | 126 | Q15283 | |
| SDWKIEHSGAFNLAG | 841 | Q8TE59 | |
| TLCQGEWKASFEELH | 261 | Q63HM1 | |
| GDVDFHNSDWDIKTI | 431 | O60890 | |
| WTEIFSGKSVAHEDI | 96 | Q9H3S7 | |
| TLFDSHEEFNEWFSK | 701 | Q9ULG1 | |
| EWFSKDIESHAENKS | 711 | Q9ULG1 | |
| HTATVDGKTILVDFW | 61 | Q9UBK7 | |
| TWHDESGIYANSDVK | 201 | Q5VTT2 | |
| FLINSSGDIFLEKHW | 6 | P53677 | |
| TDDKGFTAIHFAAQW | 136 | Q8N9V6 | |
| KLYSDWLSVGHVDEF | 461 | Q9UM07 | |
| DTHFDDEETWTFGSK | 206 | Q9NPA2 | |
| FLDKTLNASFHWLGS | 14281 | Q8WXI7 | |
| RHSGDDSQKWVFGTD | 746 | M0R2J8 | |
| HSSFGESVSLLWKVD | 561 | Q14667 | |
| TFATDIAELWAVFHK | 246 | O95461 | |
| SGHLTKLLEDDFWAD | 4551 | Q9NU22 | |
| NSFHVKWDEVSTVEG | 371 | Q9Y5Z7 | |
| HESGWKAFDVTEAVN | 171 | O75610 | |
| IFFKAWLHNSGTDQE | 221 | Q8TC57 | |
| IADHLFWSEETKSRF | 226 | Q96GA3 | |
| HFWDGKITEEEVISG | 256 | Q8IYB1 | |
| TAAVDFTKKDHTATW | 116 | Q5H8A3 | |
| FTIAATDDNHIFAWG | 661 | Q8TD19 | |
| AESSIATWHGDDFKD | 561 | Q8NI17 | |
| HKTLSIDQDEFWAFS | 141 | Q5VYY2 | |
| FWLGEAAAVTSLHKD | 166 | P0C870 | |
| FSKISWLGIHEDSIN | 341 | Q58FF6 | |
| WENGTSEKYILHDAS | 1116 | A6NM62 | |
| SLSETEKTDNFSIHW | 251 | Q68D85 | |
| QKVFFDLWEEHISSS | 71 | Q7Z3E5 | |
| WKAESISLDFGDHQA | 2206 | Q15652 | |
| KIWEDGSSDHSTYIV | 4696 | Q2LD37 | |
| DVFGDIFWKETTLAH | 611 | Q8NCM2 | |
| IAAHGFSSKEIITFW | 306 | O75752 | |
| SGFQDKEELTWEDFH | 911 | Q9NRD8 | |
| VQLDETEKAFSHFWS | 296 | Q86YR7 | |
| LWDAISTYDGSKALH | 151 | P08833 | |
| FEAFGDRVKHWITFS | 186 | Q6UWM7 | |
| FIIHGFIDKGDESWV | 91 | P54315 | |
| KATLELTHNWGTEDD | 96 | Q04760 | |
| VHKSWDSFFREASEE | 66 | Q9ULD0 | |
| WSEKVTEEFFHQGDI | 376 | Q13946 | |
| FREWAHFTGNSTLSE | 386 | Q9NP56 | |
| SWDFNIFELEAITHK | 556 | O95263 | |
| LEHSWKALVYDGDTV | 361 | O14986 | |
| TTSKTKADNIFWGEH | 201 | Q9UJF2 | |
| KRSSAFVFELSGEHW | 96 | Q9BYS8 | |
| HDSWKFAGELEQALS | 156 | A8MZA4 | |
| SRLHDSWKFAGELEQ | 116 | H0YM25 | |
| SWHQIDTFFLTKEGA | 346 | O75023 | |
| LLFAVFDEGKSWHSE | 216 | P00451 | |
| VKEFLISSSQDGHQW | 2276 | P00451 | |
| TDWSFKLDGVLHDAS | 51 | Q9HAQ2 | |
| ETLQFGHFSSASDVW | 816 | Q5JZY3 | |
| SFLKSEFGLVWHEIV | 176 | Q9H244 | |
| VWEITGAEFSKSEAH | 781 | P49916 | |
| EDVKRHSSASFENVW | 1136 | P35568 | |
| TAAWFSHDEVATALK | 296 | Q86X67 | |
| DWVLEAASFHDIFDK | 106 | Q8TCD6 | |
| LFGKVWIESAETHVS | 361 | P09884 | |
| VILNKGHDFSVDFWS | 621 | Q13237 | |
| EKDTWLYHLTVAAGS | 906 | Q8IVE3 | |
| VKQHSFFRDLDWTGL | 641 | Q9Y2H9 | |
| QVLVESDWLDFGHKF | 436 | Q9NYA4 | |
| GHSWALSAIDELKVD | 456 | O75694 | |
| TFESHKDEIFQVHWS | 311 | Q16576 | |
| HDWTLCFTGDSKLAS | 896 | P78509 | |
| SWFDDHKNSTGALST | 801 | P21439 | |
| CLSSVFVSEDGHWKL | 126 | Q8IZE3 | |
| HVQDFTAFWDKASET | 411 | O15439 | |
| VDDTLAFWSKHVDGD | 76 | P04070 | |
| AGFTEEKDHLEWDLT | 271 | Q9H237 | |
| FSESQWSHAKIDLIA | 586 | Q5VYJ5 | |
| WSHAKIDLIAEAGES | 591 | Q5VYJ5 | |
| HSEPSWFKDIKFDDS | 461 | Q9Y2I7 | |
| DLLTHEWTDGIFSSF | 1916 | Q9P2D7 | |
| HPELEFSSDFGSWDK | 1391 | A4FU69 | |
| EAHAAWDKFLSVVSS | 121 | P02008 | |
| KGTFLHSENSAFESW | 266 | Q711Q0 | |
| SESFTEEGLDLHYWK | 761 | O60308 | |
| ETHLETNFTLKSEWA | 151 | P40189 | |
| AAEHLGWSFENSLKD | 1381 | Q4AC94 | |
| VEDTFSWLRKDHSAS | 316 | Q9H4Z3 | |
| FDSLDKHTQWGIDFL | 11 | Q5T0N5 | |
| SLWSKAADLFESEGA | 296 | Q9H0R6 | |
| WDVEKTAIFAFNISH | 2756 | P35555 | |
| KTEFSESAALETFGW | 671 | Q5SYB0 | |
| AIHFGVFTIKADVWS | 406 | P51451 | |
| VASAHTAKILSWDEF | 1021 | Q8IZJ3 | |
| SGSGWDEFTKHVTSE | 176 | P15924 | |
| LEFKSHQWFGASVRS | 116 | P06756 | |
| KESTWALIHSVSDAF | 111 | P51795 | |
| IFLVDSSWTIGEEHF | 41 | P12111 | |
| VHGGSWILFDETNFE | 1391 | Q8N1P7 | |
| ASWLAAELSKEGHQV | 346 | Q9UMR2 | |
| SVSHEWSDGVLAVSF | 1661 | Q8WXX0 | |
| FVVGSDLKDAHLTWE | 191 | P01880 | |
| QDWFDEDFGLSSSHK | 2871 | Q5VT06 | |
| SAGHDGSIFIWDITK | 486 | Q9NSI6 | |
| HESGWKAFDVTEAVN | 171 | O00292 | |
| ITFVTDESGDHTGWK | 276 | O00187 | |
| KHASWNGLTVADLVF | 296 | Q68CP4 | |
| DAEILSHVFQWLGFT | 306 | Q92851 | |
| SSFITHLDWSKDGNF | 726 | Q32P44 | |
| EFLSHQAWGAVKVLS | 3791 | Q9NYC9 | |
| NWGLDSYSHKEDASA | 336 | Q5W0V3 | |
| NTSDGEWHFVEVIFA | 561 | P82279 | |
| SWLAAELSKEGHQVA | 346 | Q9NUU7 | |
| LFVHSAEGSEFWSAL | 166 | P17655 | |
| VGEFFSHVVWKATDF | 81 | Q9NTJ5 | |
| NAWHFISESVSVKED | 3246 | Q9NZJ4 | |
| LAFSDSSKWVFEHPE | 16 | P20273 | |
| ISLDGWEENHTEKFL | 96 | Q86WN2 | |
| GFVHSKTCLSWEFSE | 991 | Q2NKX8 | |
| FAHLELQGSWELFTT | 961 | Q6ZUA9 | |
| FTDTESRDHGASWFK | 406 | Q99683 | |
| SRDHGASWFKKAFES | 411 | Q99683 | |
| SKDNEGSWFRSLFVH | 36 | Q9BPW8 | |
| KEDSFEVWLSDGKHT | 1276 | P0C091 | |
| QHDGEVKAEASWDSA | 1216 | Q9NQT8 | |
| KESTDDFGSWSVHTD | 266 | O95197 | |
| DFGSWSVHTDKESSE | 271 | O95197 | |
| HVVSGADDYTVKLWD | 136 | Q8TED0 | |
| ILTDEAVSGWKFEIH | 131 | Q93008 | |
| IKSNSFFEGVDWEHI | 376 | Q15208 | |
| AKFSLTSELHWADGF | 66 | Q9H628 | |
| EWDSFFDESGHLAKS | 31 | Q8IYX1 | |
| TKWDHFGSNFETLSV | 1446 | Q8NF91 | |
| SKLTHSVSDSLFGWE | 501 | O14513 | |
| SVSDSLFGWETNRKH | 506 | O14513 | |
| DSVESAEKEIGLWFH | 121 | P15531 | |
| WEDAQGFSALLHSGK | 491 | Q9HB63 | |
| KEEDSIWFHSAEAQD | 96 | Q9NP60 | |
| NFILFSGDVSTWKEH | 321 | Q06033 | |
| TGDNTAEWDHLKISI | 616 | Q14697 | |
| LKFSVDEGLTWSTHN | 586 | Q96PQ0 | |
| ASIREKAGHWFATTT | 2551 | Q9NT68 | |
| AVKHDLAESFPFWAS | 456 | Q6ZUB0 | |
| DISNGLDWSLDHKIF | 151 | Q15493 | |
| KSDVWSFGVLLHEVF | 406 | Q9H3Y6 | |
| IITGHADGSVKFWDA | 451 | Q5T5C0 | |
| ADGSVKFWDASAITL | 456 | Q5T5C0 | |
| GESFAHSIKTWFESV | 316 | O15091 | |
| AFDWDDETAKASKQH | 151 | Q13438 | |
| EEGLTYKFHAAWSSV | 476 | Q5JTH9 | |
| VFASHIDKSAWLEAQ | 311 | O00463 | |
| INSGHSDAATIAEWK | 1766 | Q01082 | |
| EFKIDFPTRHDWDSF | 116 | Q02040 | |
| LWLITAFHDKGSLTD | 261 | Q13705 | |
| AALGDEIFLHSSWIK | 341 | Q9Y471 | |
| TFDAGAKVAVFTWHG | 56 | Q92989 | |
| GEVDLHQLASTWAKA | 91 | Q9NQ89 | |
| ELHSKQSWDFGLDEI | 436 | Q86WS4 | |
| KLTQEESFSVWDEHF | 1086 | O75122 | |
| ESFSVWDEHFKTILL | 1091 | O75122 | |
| NESWIKSHFSRLSEE | 31 | Q5T681 | |
| EEVIGSELKHWATFA | 146 | Q9UQ49 | |
| SVDDHFAKALGDTWL | 236 | Q14135 | |
| AIEDWSHFVSSAGEF | 186 | Q6URK8 | |
| LWGSDHFKEGSSQSE | 291 | Q9NZR4 | |
| VSAKDLAGQLTDHDW | 661 | O95398 | |
| AVKHDLAESFPFWAS | 456 | P0C874 | |
| KIESDAFSWLGHLEV | 421 | O15455 | |
| EAFDWEKAGTDALLS | 306 | Q5TCY1 | |
| FEDVAVHFTKTEWTG | 16 | P17023 | |
| ITWFIDGSFLHDEKE | 301 | P40200 | |
| IWSSAHTFFVLSADE | 2326 | Q99973 | |
| HTFFVLSADEKISEW | 2331 | Q99973 | |
| SKLDSWEEHIFSAFG | 216 | Q9H2W2 | |
| FWKDEGSDSHFTLDP | 186 | Q9Y6Q2 | |
| DVKGDEVHITFDGWS | 196 | Q9UQR0 | |
| HLTEKLFWGIFDSLS | 2536 | Q15413 | |
| NYHASDVLETSGWKS | 326 | O43791 | |
| WLQSLITDAFHDKGF | 26 | Q5T4T6 | |
| VLTGDWKHGFFSLTA | 306 | Q9UG56 | |
| STDDHSNWFIIGSKT | 386 | Q8NEM7 | |
| ITFGDVAIDFSHQEW | 6 | Q96SK3 | |
| DFWEGIKAHNAVVTS | 831 | Q5JSH3 | |
| TSPKEFFVDEHSAVW | 206 | Q6UXR4 | |
| KDLFISDFWSSALET | 71 | Q9UH36 | |
| TFATDPNSEWKEHAE | 241 | Q9NVG8 | |
| TTDDSLREHFEKWGT | 46 | P51991 | |
| HEAFEKSTASWAERF | 2051 | P11277 | |
| KTADHFWTDPSADEL | 186 | Q2NKQ1 | |
| EELLDSTFSWYHGAL | 476 | Q9BWH6 | |
| AFATTHWVVTEDGKI | 36 | Q96AE7 | |
| TSKDLRAAVHNGFWF | 121 | Q13530 | |
| SDSQEEAHGKLVLWS | 96 | Q99835 | |
| DEKVHGSSEAFWILV | 1211 | O75643 | |
| TIVKSHGFWLLFDDD | 316 | P62068 | |
| SFRGISEHESNLVWK | 211 | Q8NF99 | |
| ELEKTFGWSHLEALF | 101 | Q13342 | |
| HKFEIDFLCGWSLSE | 96 | Q9NRZ5 | |
| GTFTDDLHKLVDEWT | 2156 | Q9Y3S1 | |
| DSWIENDSLSVDKHG | 1181 | P48553 | |
| GQWEDASLLSKRSFH | 46 | Q969E3 | |
| FKEVEENWSKHFSSD | 911 | Q5T4S7 | |
| SEVFSDAAKEGWLHF | 926 | Q5T5U3 | |
| EVFKHDSAVWYLDGS | 241 | Q8TC26 | |
| SFWTFLHLESTFEEK | 1436 | O60293 | |
| KSFWTRHFSADEFGI | 156 | Q8NBT3 | |
| FGWFSNHSSIESDKI | 351 | Q86VY4 | |
| DWRSTVHGAVKFAFD | 866 | O76024 | |
| WSDQLSGFSLHANKD | 256 | Q9C0D4 | |
| WAVSALSEEVSHFEK | 131 | Q96M32 | |
| DAVWSGATFITHLFN | 221 | Q9Y303 |